Position history for Centiva Capital, LP's holdings in REGENERON PHARMACEUTICALS
Centiva Capital, LP holds 14,610 shares of REGN (REGENERON PHARMACEUTICALS), worth $11.3M as of 2026-Q1. This is a new position. REGN represents 0.1% of Centiva Capital, LP's portfolio.
Current Value
$11.3M
Current Shares
14,610
Total Value Change
+$11.2M
Total Shares Change
+14,544
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
New |
| 14,610 |
- |
| $11.3M |
| 0.1% |
| $766.66 |
38 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $560.05 | 0 |
| 2025-Q2 | New | 431 | - | $226,275 | 0.0% | $519.56 | 32 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $634.66 | 0 |
| 2024-Q4 | New | 604 | - | $430,247 | 0.0% | $698.71 | 33 |
| 2024-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $1,036.94 | 0 |
| 2024-Q2 | Decreased | 66 | -86.5% | $69,368 | 0.0% | $1,045.23 | 0 |